24 May 2013
Keywords: merck, kgaa, erbitux, cleared, switzerland, its, first
Article | 08 December 2003
Germany's Merck KGaA has been granted marketing authorization by theSwiss Agency for Therapeutic Products (Swissmedic) for the use of
Erbitux ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 December 2003
23 May 2013
© 2013 thepharmaletter.com